Jailendra Singh
Stock Analyst at Truist Securities
(0.91)
# 3,612
Out of 4,784 analysts
174
Total ratings
27.08%
Success rate
-24.27%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Maintains: Buy | $50 → $46 | $30.54 | +50.62% | 5 | Mar 18, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $45 | $37.83 | +18.95% | 1 | Mar 14, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $24 → $39 | $29.14 | +33.84% | 8 | Feb 26, 2025 | |
| AMWL American Well | Maintains: Hold | $10 → $12 | $7.82 | +53.45% | 6 | Feb 14, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $284 → $262 | $179.07 | +46.31% | 8 | Feb 13, 2025 | |
| IQV IQVIA Holdings | Reiterates: Buy | $261 → $263 | $177.39 | +48.26% | 14 | Feb 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $15 | $9.60 | +56.25% | 4 | Jan 22, 2025 | |
| VEEV Veeva Systems | Maintains: Hold | $261 → $210 | $234.21 | -10.34% | 7 | Jan 13, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $34 | $26.00 | +30.77% | 5 | Dec 11, 2024 | |
| DOCS Doximity | Maintains: Hold | $35 → $49 | $58.51 | -16.25% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $26 → $19 | $21.90 | -13.24% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $22.59 | +19.52% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $415 → $397 | $312.36 | +27.10% | 2 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7.5 | $6.99 | +7.30% | 15 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $10 | $8.09 | +23.61% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.19 | +14.85% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $4.49 | +44.77% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7.5 → $8 | $4.50 | +77.78% | 11 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $6.58 | +97.57% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $8.58 | +401.17% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.94 | +716.33% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $3.40 | +17.65% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $136.44 | -57.49% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $12.38 | +263.49% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $668.06 | -50.15% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.59 | +150.70% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $19.14 | - | 3 | Jan 15, 2021 |
Astrana Health
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $30.54
Upside: +50.62%
Waystar Holding
Mar 14, 2025
Initiates: Buy
Price Target: $45
Current: $37.83
Upside: +18.95%
Hims & Hers Health
Feb 26, 2025
Maintains: Hold
Price Target: $24 → $39
Current: $29.14
Upside: +33.84%
American Well
Feb 14, 2025
Maintains: Hold
Price Target: $10 → $12
Current: $7.82
Upside: +53.45%
ICON Public Limited Company
Feb 13, 2025
Maintains: Buy
Price Target: $284 → $262
Current: $179.07
Upside: +46.31%
IQVIA Holdings
Feb 10, 2025
Reiterates: Buy
Price Target: $261 → $263
Current: $177.39
Upside: +48.26%
Evolent Health
Jan 22, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $9.60
Upside: +56.25%
Veeva Systems
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $234.21
Upside: -10.34%
Phreesia
Dec 11, 2024
Maintains: Buy
Price Target: $31 → $34
Current: $26.00
Upside: +30.77%
Doximity
Nov 14, 2024
Maintains: Hold
Price Target: $35 → $49
Current: $58.51
Upside: -16.25%
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $21.90
Upside: -13.24%
Nov 8, 2024
Maintains: Buy
Price Target: $24 → $27
Current: $22.59
Upside: +19.52%
Oct 14, 2024
Maintains: Hold
Price Target: $415 → $397
Current: $312.36
Upside: +27.10%
Oct 9, 2024
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.99
Upside: +7.30%
Aug 2, 2024
Maintains: Hold
Price Target: $15 → $10
Current: $8.09
Upside: +23.61%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.19
Upside: +14.85%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $4.49
Upside: +44.77%
Mar 1, 2024
Maintains: Hold
Price Target: $7.5 → $8
Current: $4.50
Upside: +77.78%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $6.58
Upside: +97.57%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $8.58
Upside: +401.17%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.94
Upside: +716.33%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $3.40
Upside: +17.65%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $136.44
Upside: -57.49%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $12.38
Upside: +263.49%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $668.06
Upside: -50.15%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.59
Upside: +150.70%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $19.14
Upside: -